Evgeniy Panzhinskiy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Evgeniy Panzhinskiy has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- James D. Johnson
Department of Cellular and Physiological Sciences, Life Sciences Institute, University of British Columbia, Vancouver, Canada
3 shared publications - Cameron Bruce Verchere
Department of Surgery, University of British Columbia
2 shared publications - Jiashuo Aaron Zhang
Department of Physiology, Anatomy and Genetics (K.M.J.H.D., C.N.M.A., J.A.Z., M.C.-G., T.N., R.M.D., R.D.C., U.P., C.A.C., G.S., E.K.G., P.S., S.D.V., L.C.H.), University of Oxford, United Kingdom
2 shared publications - Søs Skovsø
Life Sciences Institute, Department of Cellular and Physiological Sciences & Department of Surgery, University of British Columbia, Vancouver, Canada
2 shared publications Amanda Rahardjo
Life Sciences Institute, Department of Cellular and Physiological Sciences & Department of Surgery, University of British Columbia, Vancouver, Canada
1 shared publication- Austin J. Taylor
Departments of Surgery and Pathology and Laboratory Medicine, Faculty of Medicine, BC Children’s Hospital Research Institute and Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada
1 shared publication
Latest Publications
- 30 April 2025
- Published by Springer Nature in Diabetologia
- Vol. 68 (8) , 1735-1753
Eukaryotic translation initiation factor 2A protects pancreatic beta cells during endoplasmic reticulum stress while rescuing global translation inhibition
Aims/hypothesis The endoplasmic reticulum (ER) stress-induced unfolded protein response helps determine beta cell survival rate in diabetes. The alternative eukaryotic translation initiation factor 2A (EIF2A) has been proposed to mediate translation initiation independent of the α subunit of EIF2 (EIF2S1) during cellular stress, but its role in beta cells has not been comprehensively examined. Methods For in vitro experiments, we used MIN6 cells, primary mouse pancreatic islets, and human islets obtained under informed consent. Thapsigargin (1 µmol/l) or palmitate complexed with BSA (0.5 mmol/l) was used to induce ER stress. Transient transfection and lentiviral infection were used for transgene delivery. For in vivo experiments, adeno-associated viral particles expressing EIF2A or GFP under the control of a rat insulin promoter were delivered via intraductal injection to 6-week-old female Akita mice randomised into three groups (two cohorts, n=10–11). Tail blood was collected for blood glucose measurements for single time points as well as during glucose and insulin tolerance tests. Results EIF2A protein abundance and specificity was high in human and mouse islets relative to other tissues. We used STRING and AlphaFold pulldown to predict interacting proteins and binding partners, verifying EIF1AX with co-immunoprecipitation. Both thapsigargin and palmitate significantly increased EIF2A mRNA and EIF2A protein levels in MIN6 cells, mouse islets and human islets. Knockdowns of EIF2A, the related factor EIF2D or both EIF2A and EIF2D were not sufficient to cause apoptosis. On the other hand, transient or stable EIF2A overexpression protected MIN6 cells, primary mouse islets and human islets from ER stress-induced, caspase-3-dependent apoptosis. Mechanistically, EIF2A overexpression decreased endoplasmic reticulum to nucleus signalling 1 (ERN1, also known as inositol-requiring enzyme 1 α or IRE1α) expression in thapsigargin-treated MIN6 cells or human islets. In vivo, beta cell-specific EIF2A viral overexpression reduced ER stress and improved insulin secretion and glucose tolerance in Ins2Akita/WT mice. EIF2A overexpression significantly increased expression of genes involved in mRNA translation and reduced expression of pro-apoptotic genes (e.g. Aldh1a3). Proteomic analysis of EIF2A-overexpressing human islets revealed significant changes in pathways associated with ribosomes and protein processing in ER. Remarkably, the decrease in global protein synthesis during unfolded protein response was prevented by EIF2A, despite ER stress-induced EIF2S1 phosphorylation. The protective effects of EIF2A were additive to those of ISRIB, a drug that counteracts the effects of EIF2S1 phosphorylation. Cells overexpressing EIF2A showed higher expression of translation factor EIF2B5, which may contribute to the lack of translational inhibition in these cells. Conclusions/interpretation We conclude that EIF2A is a novel target for beta cell protection and the circumvention of EIF2S1-mediated translational repression. Graphical Abstract
- 30 April 2025
- Published by Springer Nature in Diabetologia
- Vol. 68 (8) , 1735-1753
Eukaryotic translation initiation factor 2A protects pancreatic beta cells during endoplasmic reticulum stress while rescuing global translation inhibition
Aims/hypothesis The endoplasmic reticulum (ER) stress-induced unfolded protein response helps determine beta cell survival rate in diabetes. The alternative eukaryotic translation initiation factor 2A (EIF2A) has been proposed to mediate translation initiation independent of the α subunit of EIF2 (EIF2S1) during cellular stress, but its role in beta cells has not been comprehensively examined. Methods For in vitro experiments, we used MIN6 cells, primary mouse pancreatic islets, and human islets obtained under informed consent. Thapsigargin (1 µmol/l) or palmitate complexed with BSA (0.5 mmol/l) was used to induce ER stress. Transient transfection and lentiviral infection were used for transgene delivery. For in vivo experiments, adeno-associated viral particles expressing EIF2A or GFP under the control of a rat insulin promoter were delivered via intraductal injection to 6-week-old female Akita mice randomised into three groups (two cohorts, n=10–11). Tail blood was collected for blood glucose measurements for single time points as well as during glucose and insulin tolerance tests. Results EIF2A protein abundance and specificity was high in human and mouse islets relative to other tissues. We used STRING and AlphaFold pulldown to predict interacting proteins and binding partners, verifying EIF1AX with co-immunoprecipitation. Both thapsigargin and palmitate significantly increased EIF2A mRNA and EIF2A protein levels in MIN6 cells, mouse islets and human islets. Knockdowns of EIF2A, the related factor EIF2D or both EIF2A and EIF2D were not sufficient to cause apoptosis. On the other hand, transient or stable EIF2A overexpression protected MIN6 cells, primary mouse islets and human islets from ER stress-induced, caspase-3-dependent apoptosis. Mechanistically, EIF2A overexpression decreased endoplasmic reticulum to nucleus signalling 1 (ERN1, also known as inositol-requiring enzyme 1 α or IRE1α) expression in thapsigargin-treated MIN6 cells or human islets. In vivo, beta cell-specific EIF2A viral overexpression reduced ER stress and improved insulin secretion and glucose tolerance in Ins2Akita/WT mice. EIF2A overexpression significantly increased expression of genes involved in mRNA translation and reduced expression of pro-apoptotic genes (e.g. Aldh1a3). Proteomic analysis of EIF2A-overexpressing human islets revealed significant changes in pathways associated with ribosomes and protein processing in ER. Remarkably, the decrease in global protein synthesis during unfolded protein response was prevented by EIF2A, despite ER stress-induced EIF2S1 phosphorylation. The protective effects of EIF2A were additive to those of ISRIB, a drug that counteracts the effects of EIF2S1 phosphorylation. Cells overexpressing EIF2A showed higher expression of translation factor EIF2B5, which may contribute to the lack of translational inhibition in these cells. Conclusions/interpretation We conclude that EIF2A is a novel target for beta cell protection and the circumvention of EIF2S1-mediated translational repression. Graphical Abstract
- Open Access
- 5 January 2023
- Published by Elsevier in Molecular Metabolism
- Vol. 68, 101667
Islet amyloid polypeptide does not suppress pancreatic cancer
- 5 January 2023
- Published by Elsevier in Molecular Metabolism
- Vol. 68, 101667
Open AccessIslet amyloid polypeptide does not suppress pancreatic cancer
- Open Access
Sex differences in islet stress responses support female beta cell resilience
Objective: Pancreatic β cells play a key role in glucose homeostasis; dysfunction of this critical cell type causes type 2 diabetes (T2D). Emerging evidence points to sex differences in β cells, but few studies have examined male-female differences in β cell stress responses and resilience across multiple contexts, including diabetes. Here, we address the need for high-quality information on sex differences in β cell/islet gene expression and function using both human and rodent samples. Methods: We compared β cell gene expression and insulin secretion in donors living with T2D to non-diabetic donors in both males and females. In mice, we generated a well-powered islet RNAseq dataset from 20-week-old male and female siblings with equivalent insulin sensitivity. Because on our unbiased analysis of gene expression pointed to sex differences in endoplasmic reticulum (ER) stress response, we subjected islets isolated from age-matched male and female mice to thapsigargin treatment and monitored protein synthesis, cell death, and β cell insulin production and secretion. Transcriptomic and proteomic analyses were used to characterize sex differences in islet responses to ER stress. Results: Our single-cell analysis of human β cells revealed sex-specific changes to gene expression and function in T2D, correlating with more robust insulin secretion in islets isolated from female donors living with T2D compared to male T2D donors. In mice, RNA sequencing revealed differential enrichment of unfolded protein response pathway-associated genes, where female islets showed higher expression of genes linked with protein synthesis, folding, and processing. This differential expression was biologically significant, as female islets were more resilient to ER stress induction with thapsigargin. Specifically, female islets maintained better insulin secretion and showed a distinct transcriptional response under ER stress compared with males. Conclusions: Our data demonstrate that physiologically significant sex differences in β cell gene expression exist in both humans and mice, and that female β cells maintain better insulin production and secretion across multiple physiological and pathological contexts.
Open AccessSex differences in islet stress responses support female beta cell resilience
Objective: Pancreatic β cells play a key role in glucose homeostasis; dysfunction of this critical cell type causes type 2 diabetes (T2D). Emerging evidence points to sex differences in β cells, but few studies have examined male-female differences in β cell stress responses and resilience across multiple contexts, including diabetes. Here, we address the need for high-quality information on sex differences in β cell/islet gene expression and function using both human and rodent samples. Methods: We compared β cell gene expression and insulin secretion in donors living with T2D to non-diabetic donors in both males and females. In mice, we generated a well-powered islet RNAseq dataset from 20-week-old male and female siblings with equivalent insulin sensitivity. Because on our unbiased analysis of gene expression pointed to sex differences in endoplasmic reticulum (ER) stress response, we subjected islets isolated from age-matched male and female mice to thapsigargin treatment and monitored protein synthesis, cell death, and β cell insulin production and secretion. Transcriptomic and proteomic analyses were used to characterize sex differences in islet responses to ER stress. Results: Our single-cell analysis of human β cells revealed sex-specific changes to gene expression and function in T2D, correlating with more robust insulin secretion in islets isolated from female donors living with T2D compared to male T2D donors. In mice, RNA sequencing revealed differential enrichment of unfolded protein response pathway-associated genes, where female islets showed higher expression of genes linked with protein synthesis, folding, and processing. This differential expression was biologically significant, as female islets were more resilient to ER stress induction with thapsigargin. Specifically, female islets maintained better insulin secretion and showed a distinct transcriptional response under ER stress compared with males. Conclusions: Our data demonstrate that physiologically significant sex differences in β cell gene expression exist in both humans and mice, and that female β cells maintain better insulin production and secretion across multiple physiological and pathological contexts.